| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 08/14/2003 | WO2002068696A3 Methods for dna conjugation onto solid phase including related optical biodiscs and disc drive systems |
| 08/14/2003 | WO2002059610A3 Lamin alpha 4 subunit as a diagnostic indicator of malignant tumors |
| 08/14/2003 | WO2002059344A3 Gpr54 g protein-coupled receptor |
| 08/14/2003 | WO2002059154A9 Neutralizing human monoclonal antibodies against hiv-1, their production and uses |
| 08/14/2003 | WO2002058626A3 Methods and compositions for the identification and treatment of neurodegenerative disorders |
| 08/14/2003 | WO2002057795A3 Methods of diagnosis and treatment of osteoporosis |
| 08/14/2003 | WO2002057488A3 Gene detection method, detection device, and detection chip |
| 08/14/2003 | WO2002057479A3 Primers and methods for the detection and discrimination of nucleic acids |
| 08/14/2003 | WO2002057453A3 Polypetides and nucleic acids encoding same |
| 08/14/2003 | WO2002055735A3 Compositions and methods relating to prostate specific genes and proteins |
| 08/14/2003 | WO2002052036A3 Identification of modulators of dham-kinase and inflammatory diseases |
| 08/14/2003 | WO2002046453A3 Method and kit for identification of nucleic acid modification enzymes and inhibitors thereof |
| 08/14/2003 | WO2002046415A3 Polynucleotide and polypeptide sequences of putative transporters and ion channells |
| 08/14/2003 | WO2002044427A3 Cell based triple readout assay systems for identifying compounds that effect transcription |
| 08/14/2003 | WO2002036830A3 Method of determining gene copy number |
| 08/14/2003 | WO2002034947A3 Detecting specific nucleotide sequences |
| 08/14/2003 | WO2002029117A3 Methods and probes for detection and/or quantification of nucleic acid sequences |
| 08/14/2003 | WO2002029055A3 Carbohydrate-associated proteins |
| 08/14/2003 | WO2002027034A3 Method of identifying genetic regions associated with disease and predicting responsiveness to therapeutic agents |
| 08/14/2003 | WO2002020788A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 08/14/2003 | WO2002018660A3 Detection of varicella-zoster virus |
| 08/14/2003 | WO2002012497A3 Haplotypes of the nfkbib gene |
| 08/14/2003 | WO2002012434A3 A global electronic medicine response profile testing network |
| 08/14/2003 | WO2002010453A3 Molecular toxicology modeling |
| 08/14/2003 | WO2002001230A3 Rapid and sensitive detection of protein aggregation |
| 08/14/2003 | WO2002000705A3 Method and nucleic acids for the differentiation of astrocytoma, oligoastrocytoma and oligodendroglioma tumor cells |
| 08/14/2003 | WO2001098539A3 Gene markers for lung cancer |
| 08/14/2003 | WO2001092527A3 Regulators of apoptosis |
| 08/14/2003 | WO2001090421A3 Method of detecting inflammatory lung disorders |
| 08/14/2003 | WO2001090148A3 Neurotransmitter transporters |
| 08/14/2003 | WO2001090120A3 Haplotypes of the evx1 gene |
| 08/14/2003 | WO2001090115A3 Haplotypes of the cdk4 gene |
| 08/14/2003 | WO2001088196A3 Sequence based screening |
| 08/14/2003 | US20030154510 Novel delta-endotoxin gene isolated from Bacillus thuringiensis var. finitimus |
| 08/14/2003 | US20030154501 Analyzing effects of insecticides on gut of nematodes via high throughput assay |
| 08/14/2003 | US20030154499 Gene knockout; membrane proteins; lymphocytes; very low antigen (VLA-4) receptors |
| 08/14/2003 | US20030154034 Nucleic acids are contacted under conditions in which they are capable of forming a stable four-way complex that can be detected to indicate that the nucleic acids differ in genotype |
| 08/14/2003 | US20030154033 Methods and compositions for detecting differences between nucleic acids |
| 08/14/2003 | US20030153844 Integral sample collection tip |
| 08/14/2003 | US20030153740 Cloning libraries with probe which comprises hepatitis B virus (HBV); hap proteins |
| 08/14/2003 | US20030153739 Formed via cloning and expressing cDNA, then detecting missense mutations with immunoassay |
| 08/14/2003 | US20030153737 Such as 5-O-4,4'dimethoxytrityl-1,2-dideoxy-1-(o-nitrobenzyl)-D-ribofuranose-3-O-(2 -cyanoethyl-N,N'-diisopropyl) phosphoramidite for enhancing cellular uptake, lipophilicity, and retention of oligonucleotides within; antisense therapy |
| 08/14/2003 | US20030153733 Antibiotic resistant drug screening; vaccines |
| 08/14/2003 | US20030153526 Compositions contain antisense oligonucleotides that hybridize to Grb2 and Crkl nucleic acids, gene products of which are known to interact with tumorigenic protein bcr-abl |
| 08/14/2003 | US20030153525 Identifies differential expression of 1465, 1587, 2146, 2207, 32838, 336 OR 52908 genes in tissues relating to pain sensation relative to their expression in normal or non-painful disease states |
| 08/14/2003 | US20030153523 Screening library of test compounds, each of which is attached to a solid support, with a dye-labeled RNA molecule to form a dye-labeled target RNA:support-attached test compound complex |
| 08/14/2003 | US20030153519 Drug delivering a nucleic acid and an RNase inhibitor to a target cell of a vascularized multi-cellular organism; RNA interference |
| 08/14/2003 | US20030153503 Therapeutic treatment of hypoxia, anemia, and enzyme inhibitors; antihypoxic agents |
| 08/14/2003 | US20030153097 Modulation of COP9 signalsome isopeptidase activity |
| 08/14/2003 | US20030153090 Such as acetoxymethyl diacetyl-coelenterazine, which is contacted with luciferase |
| 08/14/2003 | US20030153076 Mammalian telomerase |
| 08/14/2003 | US20030153067 For contacting the immobilized cell, a hydrodynamic low pressure is generated acting on a cell membrane through a contact tip projecting into the opening |
| 08/14/2003 | US20030153066 Isolating nucleic acid putatively encoding the viral gene from the viral genome; programming a cell-free translation system with such nucleic acid, determine if capsid assembly has occurred which indicates that viral gene is required |
| 08/14/2003 | US20030153063 Polypeptides; membrane proteins for diagonsis, prevention and treatment of cardiovascular disorders |
| 08/14/2003 | US20030153061 Method for immobilizing recognition components |
| 08/14/2003 | US20030153047 AIB1, a novel steroid receptor co-activator |
| 08/14/2003 | US20030153042 Expression of functional eukaryotic proteins |
| 08/14/2003 | US20030153037 Genetic engineering; stimulant for lymphocyte cell differentiation |
| 08/14/2003 | US20030153036 Genetic engineering; stimulant for lymphocyte cell differentiation |
| 08/14/2003 | US20030153034 Genetic engineering; stimulant for lymphocyte cell differentiation |
| 08/14/2003 | US20030153033 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/14/2003 | US20030153028 Cell isolation method |
| 08/14/2003 | US20030153025 Cell-based drug screens for regulators of gene expression |
| 08/14/2003 | US20030153021 Hermetic sealed cartridge; incubation; analyzing |
| 08/14/2003 | US20030153018 Methods and compositions for treating cancer using 2192, 2193, 6568, 8895, 9138, 9217, 9609, 9857, 9882, 10025, 20657, 21163, 25848, 25968, 32603, 32670, 33794, 54476 and 94710 |
| 08/14/2003 | US20030153014 Compositions and methods for detecting protein modification and enzymatic activity |
| 08/14/2003 | US20030153009 Screening analysis; mixing kinase and inhibitor thereof; measurement; calibration |
| 08/14/2003 | US20030153007 Automated systems and methods for analysis of protein post-translational modification |
| 08/14/2003 | US20030153003 Growth hormone variants |
| 08/14/2003 | US20030152999 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/14/2003 | US20030152998 Method of preparing cell lysate |
| 08/14/2003 | US20030152997 Polymerase chain reactions; disease diagnosis; veterinary medicine |
| 08/14/2003 | US20030152996 Method for nucleotide sequencing |
| 08/14/2003 | US20030152995 Electron induced fluorescent method for nucleic acid sequencing |
| 08/14/2003 | US20030152994 Quantitative analysis; sample distribution networks |
| 08/14/2003 | US20030152992 Measuring fluorescence polarization |
| 08/14/2003 | US20030152988 Thermostable DNA polymerases incorporating nucleoside triphosphates labeled with fluorescent dyes |
| 08/14/2003 | US20030152987 Tissue analysis and kits therefor |
| 08/14/2003 | US20030152986 Method for sorting antifungal molecules acting on the glucanosyltransferase activity |
| 08/14/2003 | US20030152985 Transient electrical signal based methods and devices for characterizing molecular interaction and/or motion in a sample |
| 08/14/2003 | US20030152982 Method for the detection of the antibiotic resistance spectrum of Mycobacterium species |
| 08/14/2003 | US20030152981 Detection of chromosome disease; enzyme digestion of Dna |
| 08/14/2003 | US20030152980 Detection using antibodies; modulate gene expression |
| 08/14/2003 | US20030152979 Via ELISA or PCR to determine reproductive character/ pollination |
| 08/14/2003 | US20030152975 Screening for genes which trigger hypersensitive response in tobacco plants in presence of ubiquitous Phytophthora infestans elicitor; horticulture |
| 08/14/2003 | US20030152974 Isolation of nucleic acids on surfaces |
| 08/14/2003 | US20030152973 G-protein coupled receptor org3 |
| 08/14/2003 | US20030152972 Gene expression associated with psychiatric disorders |
| 08/14/2003 | US20030152971 Methods and compositions for detecting target sequences |
| 08/14/2003 | US20030152970 Methods and compositions to treat pain and painful disorders using 577, 20739 or 57145 |
| 08/14/2003 | US20030152968 Methods for detection of promoter polymorphism in a UGT gene promoter |
| 08/14/2003 | US20030152965 HCV core protein sequences |
| 08/14/2003 | US20030152964 Analyzing epidermus/keratinocytes via comparing nucleotide sequences in gene arrays |
| 08/14/2003 | US20030152962 Comprises assay for expression of SCIP gene (transcription factor having suppressed cAMP inducible POU domains); screening neurotoxicology/neuropathology |
| 08/14/2003 | US20030152961 Comprises bonded surface layer having both postive and negative charges for use in automatic sequence determination |
| 08/14/2003 | US20030152960 Comprises transition metal complex that oxidizes/reduces labels to create signals through common electrode; competitive binding assay |
| 08/14/2003 | US20030152959 Method of using estrogen-related receptor alpha (ERRalpha) status to determine prognosis, treatment strategy and predisposition to breast cancer, and method of using ERRalpha as a therapeutic target for the treatment of breast cancer |
| 08/14/2003 | US20030152958 Nucleic acid fragment-fixed electrode and its use |
| 08/14/2003 | US20030152957 Probe-immobilized reaction arrays |
| 08/14/2003 | US20030152956 Modulating gene expression of carboxypeptidase M, cathepsin C, endothelin-A receptor, and/or osteoblast specific factor by stimulating respiratory tract epithelial cells with interleukins; drug screening |